Hosted on MSN11mon
Aroa Biosurgery to target US$300 million trauma market with Myriad products
Aroa Biosurgery expects its Myriad portfolio to continue driving strong growth in the soft tissue reconstruction market Initially focus on trauma segment of market, which based on its estimates ...
Adelaide Now14d
Seven million strong: Aroa’s sheep-derived products hit medical use milestone
Aroa’s first Myriad product, Myriad Matrix – an extracellular matrix graft, indicated for use in soft tissue reconstruction and complex wounds – received FDA clearance in 2019. Since then ...